Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
351,47 B | 2,49% | 4/6 | 25,40% | -23,46% | 27,57% | DOWN |
|
Amgen NasdaqGS:AMGN |
185,95 B | 7,37% | 3/6 | 2,72% | -5,91% | 2,45% | UP |
|
Gilead Sciences NasdaqGS:GILD |
161,72 B | 3,31% | 5/6 | 3,83% | -43,14% | 23,19% | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
40,52 B | 46,06% | 4/6 | 49,91% | 10,83% | 46,63% | DOWN |
|
Biogen NasdaqGS:BIIB |
27,06 B | -10,57% | 1/6 | -1,25% | 4,35% | 13,08% | UP |
|
Incyte NasdaqGS:INCY |
18,84 B | 41,79% | 5/6 | 8,74% | 28,33% | 12,52% | UP |
|
Arrowhead Pharmaceuticals NasdaqGS:ARWR |
10,35 B | 48,13% | 5/6 | -45,97% | -0,79% | 19,06% | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
10,23 B | 12,22% | 5/6 | 45,50% | 61,98% | 76,76% | DOWN |
|
Blueprint Medicines NasdaqGS:BPMC |
8,38 B | 45,26% | 4/6 | 42,18% | -48,48% | 0,64% | UP |
|
Cidara Therapeutics NasdaqCM:CDTX |
6,97 B | -59,17% | 2/6 | 0,00% | -652349,57% | -100,00% | UP |
|
Arena Pharmaceuticals NasdaqGM:ARNA |
6,17 B | 0,00% | 0,00% | 0,00% | 0,00% | UP | |
|
Amicus Therapeutics NasdaqGM:FOLD |
4,55 B | 19,97% | 5/6 | 59,76% | -44,39% | 0,07% | UP |
|
Viking Therapeutics NasdaqCM:VKTX |
3,80 B | 0,00% | 0/4 | 0,00% | 0,00% | 203,82% | DOWN |
|
Travere Therapeutics NasdaqGM:TVTX |
3,74 B | 10,07% | 5/6 | 42,67% | -99,54% | 23,46% | UP |
|
ACADIA Pharmaceuticals NasdaqGS:ACAD |
3,74 B | 29,02% | 5/6 | 15,27% | -24,90% | 48,00% | DOWN |
|
ChemoCentryx NasdaqGS:CCXI |
3,74 B | 0,00% | 0/4 | 0,00% | 0,00% | -100,00% | UP |
|
CymaBay Therapeutics NasdaqGS:CBAY |
3,72 B | 0,00% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
Catalyst Pharmaceuticals NasdaqCM:CPRX |
3,34 B | 40,93% | 5/6 | 5,58% | 16,09% | 27,88% | UP |
|
Dicerna Pharmaceuticals NasdaqGM:DRNA |
2,99 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | UP |
|
Celldex Therapeutics NasdaqCM:CLDX |
2,61 B | -34,06% | 1/6 | 114,74% | -416,64% | 65,21% | UP |
